- Filed
- Dec 5, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2024 · Dec 4, 2024 | 17.57M sh |
| Short Term Investments | Q3 2024 · Oct 31, 2024 | $66.83M |
| Short Term Investments | Q3 2024 · Jan 31, 2024 | $155.26M |
| Cash And Equivalents | Q3 2024 · Oct 31, 2024 | $298.25M |
| Cash And Equivalents | Q3 2024 · Jan 31, 2024 | $223.4M |
| Stockholders Equity | Q3 2024 · Oct 31, 2024 | $564.49M |
| Stockholders Equity | Q3 2024 · Jan 31, 2024 | $513.92M |
| Current Liabilities | Q3 2024 · Oct 31, 2024 | $43.96M |
| Current Liabilities | Q3 2024 · Jan 31, 2024 | $66.26M |
| Current Assets | Q3 2024 · Oct 31, 2024 | $436.5M |
| Current Assets | Q3 2024 · Jan 31, 2024 | $452.1M |
| Total Assets | Q3 2024 · Oct 31, 2024 | $715.66M |
| Total Assets | Q3 2024 · Jan 31, 2024 | $664.8M |
| Shares Diluted | Q3 2024 · Oct 31, 2023 | 17.53M sh |
| Shares Diluted | Q3 2024 · Oct 31, 2023 | 17.46M sh |
| Capex | Q3 2024 · Oct 31, 2023 | $22.36M |
| Operating Cash Flow restated | Q3 2024 · Oct 31, 2023 | $65.46M |
| Eps Diluted | Q3 2024 · Oct 31, 2023 | $1.49 |
| Eps Diluted | Q3 2024 · Oct 31, 2023 | $2.31 |
| Eps Basic | Q3 2024 · Oct 31, 2023 | $1.49 |
| Eps Basic | Q3 2024 · Oct 31, 2023 | $2.31 |
| Sga Expense | Q3 2024 · Oct 31, 2023 | $7.61M |
| Sga Expense | Q3 2024 · Oct 31, 2023 | $22M |
| Gross Profit | Q3 2024 · Oct 31, 2023 | $39.29M |
| Gross Profit | Q3 2024 · Oct 31, 2023 | $67.81M |